Abstract
Since the discovery of the human immunodeficiency viruses types 1 (HIV-1) and 2 (HIV-2) as the causative agents of acquired immunodeficiency syndrome (AIDS) (Barre-Sinoussi et al. 1983; Clavel et al. 1987; Papovic et al. 1984) and the isolation of related lentiviruses from several species of Old World monkeys, much has been learned about their biology and evolution. Based on genetic analysis, five distinct phylogenetic lineages of primate lentiviruses have now been identified: HIV-1/simian immunodeficiency virus (SIV)CPZ, HIV-2/SIVSM/SIVMAC, SIVAGM, SIVMND, and SIVSYK (for review see Johnson et al. 1991; Myers et al. 1992; Sharp et al. 1994). Like all retroviruses, primate lentiviruses are similar in structure and genomic organization. They contain gag, pol, and env genes that encode structural proteins essential for virion architecture (Gag), glycoproteins that enable the virus to recognize and infect its target (Env), and enzymatic proteins essential for processes of virus maturation, reverse transcription, and integration (Pol). While the genomic structure of all five lineages is conserved, differences exist in the composition of auxiliary genes: all five groups of viruses contain tat, rev, nef and vif all but SIVAGM contain vpr, only HIV-1/SIVSYK contains vpu, and only HIV-2/SIVSM/SIVMAC and SIVAGM viruses contain vpx (Cullen and Green 1990; Johnson et al. 1991). Primate lentiviruses have complex life cycles regulated by interactions of viral structural and accessory gene products as well as host factors (Cullen 1991). Viral accessory genes modulate replication, host cell tropism, chronic persistence, and pathogenicity. Defining the role of viral accessory genes is critical for understanding the natural history of infection and disease pathogenesis and thus represents a major goal in biomedical AIDS research. Moreover, knowledge of accessory protein function may facilitate the development of therapeutic and vaccine interventions. In this chapter the author reviews the present understanding of the role of Vpx in the HIV-2/SIV life cycle and the structure-function relationships that mediate incorporation of this protein into virions. Based on genetic and phylogenetic evidence indicating that in the HIV-2/ SIVSM/SIVMAC lineage vpxarose from a gene duplication of vpr and on the proposed reclassification of SIVAGM vpx to vpr (Tristem et al. 1990, 1992), for clarity this review will discuss vpx for only the HIV-2/SIVSM/SIVMAC group of viruses.
Keywords
- Human Immunodeficiency Virus
- Acquire Immune Deficiency Syndrome
- Simian Immunodeficiency Virus
- Amphipathic Helix
- Acquire Immune Deficiency Syndrome Virus
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akari H, Sakuragi J, Takebe Y, Tomonaga K, Kawamura M, Fukasawa M, Miura T, Shinjo T, Hayami M (1992) Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells. Arch Virol 123: 157–167
Arrigo SJ, Chen ISY (1991) Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr and env/vpu 2 RNAs. Genes Dev 5: 808–819
Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Giuest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L (1983) Isolation of a T-lymphotropic retrovirus from at patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868–870
Chakrabarti L, Guyader M, Alizon M, Daniel MD, Desrosiers RC, Tiollais P, Sonigo P (1987) Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature 328: 543–547
Clavel F, Mansinho K, Chamaret S, Guetard D, Favier V, Nina J, Santos-Ferreira M-D, Champalimaud J-L, Montagnier L (1987) Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med 316: 1180–1185
Cohen EA, Dehni G, Sodroski JG, Haseltine WA (1990a) Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol 64: 3097–3099
Cohen EA, Terwilliger EF, Jalinoos Y, Proulx J, Sodroski JG, Haseltine WA (1990b) Identification of HIV-1 Vpr product and function. JAIDS 3: 11–18
Cullen BR (1991) Human immunodeficiency virus as a prototypic complex retrovirus. J Virol 65: 1053–1056
Cullen BR, Green WC (1990) Functions of the auxiliary gene products of the human immunodeficiency virus type 1. Virology 178: 1–5
Dedera D, Hu W, Vander-Hyden N, Ratner L (1989) Viral protein R of human immunodeficiency virus types 1 and 2 is dispensable for replication cytopathogenicity in lymphoid cells. J Virol 63: 3205–3208
Dong J, Hunter E (1993) Analysis of retroviral assembly using a vaccinia/T7-polymerase complementation system. Virology 194: 192–199
Franchini G, Gurgo C, Guo H-G, Gallo RC, Collalti E, Fargnoli KA, Hall LF, Wong-Staal F, Reitz MS Jr (1987) Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses. Nature 328: 539–542
Franchini G, Rusche JR, O’Keeffe TJ, Wong-Staal F (1988) The human immunodeficiency virus type 2 (HIV-2) contains a novel gene encoding a 16 kDa protein associated with mature virions. AIDS Res Hum Retro Viruses 4: 243–250
Fuerst RT, Niles EG, Studier W, Moss B (1986) Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci USA 83: 8122–8126
Fuerst RT, Earl PL, Moss B (1987) Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol Cell Biol 7: 2538–2544
Garette ED, Tiley JS, Cullen BR (1991) Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products. J Virol 65: 1653–1657
Gelderblom HR (1991) Assembly and morphology of HIV: potential effects of structure on viral function. AIDS 5: 617–638
Gibbs JS, Regier DA, Desrosiers RC (1994) Construction and in vitro properties of SIVMAC mutants with deletions “in nonessential” genes. AIDS Res Hum Retro Viruses 10: 607–616
Guyader M, Emerman M, Sonigo P, Clavel F, Montagnier L, Alizon M (1987) Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 326: 662–669
Guyader M, Emerman M, Montagnier L, Peden K (1989) Vpx mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes. EMBO J 8: 1169–1175
Hattori N, Michaels F, Fargnoli K, Marcon L, Gallo RC, Franchini G (1990) The human immunodeficiency virus type 2 Vpr gene is essential for productive infection of human macrophages. Proc Natl Acad Sci USA 87: 8080–8084
Henderson LE, Benveniste RE, Sowder R, Copeland TD, Schultz AM, Oroszlan S (1988a) Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne). J Virol 62: 2587–2595
Henderson LE, Sowder RC, Copeland TD, Benveniste RE, Oroszlan S (1988b) Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2. Science 241: 199–201
Horton R, Spearman P, Ratner L (1994) HIV-2 viral protein X associates with the Gag p27 capsid protein. Virology 199: 453–457
Hu W, Vander-Heyden N, Ratner L (1989) Analysis of the function of the viral protein X (VPX) of HIV-2. Virology 173: 624–630
Johnson PR, Myers G, Hirsch VM (1991) Genetic diversity and phylogeny of non-human primate lentiviruses. In: Koff WC, Wong-Staal F, Kennedy RC (eds) AIDS research reviews, vol 1. Dekker, New York; pp 47–62
Jones MK, Anantharamaiah GM, Segrest JP (1992) Computer programs to identify and classify amphipathic alpha helical domains. J Lipid Res 33: 287–296
Kappes JC, Parkin JS, Conway JA, Kim J, Brouillette CG, Shaw GM, Hahn BH (1993) Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components. Virology 193: 222–233
Kappes JC, Conway JA, Lee S-VV, Shaw GM, Hahn BH (1991) Human immunodeficiency virus type 2 vpx protein augments viral infectivity. Virology 184: 197–209
Kappes JC, Morrow CD, Lee S-W, Jameson BA, Kent SB, Hood LE, Shaw GM, Hahn BH (1988) Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC. J Virol 62: 3501–3505
Kumar P, Hui H, Kappes JC, Haggarty BS, Hoxie JA, Arya SK, Shaw GM, Hahn BH (1990) Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate. J Virol 64: 890–891
Lavallée C, Yao XJ, Ladha A, Gottlinger H, Haseltine WA, Cohen EA (1994) Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles. J Virol 68: 1926–1934
Lu Y-L, Spearman P, Ratner L (1993) Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J Virol 67: 6542–6550
Marcon L, Michaels F, Hattori N, Fargnoli K, Gallo RC, Franchini G (1991) Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication. J Virol 65: 3938–3942
Myers G, Maclnnes K, Korber B (1992) The emergence of simian/human immunodeficiency viruses. AIDS Res Hum Retro viruses 8: 373–386
Natsoulis G, Boeke JD (1991) New antiviral strategy using capsid-nuclease fusion proteins. Nature 352: 632–635
Ogawa K, Shibata R, Kiyomasu T, Higuchi I, Kishida Y, Ishimoto A, Adachi A (1989) Mutational analysis of the human immunodeficiency virus vpr open reading frame. J Virol 63: 4110–4114
Papovic M, Sarngadharan MG, Read E, Gallo RC (1984) Detection, isolation and continuous culture production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224: 497–500
Paxton W, Conner RI, Landau NR (1993) Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 regions of gag and mutational analysis. J Virol 67: 7229–7237
Ratner L, Haseltine W, Patarca R, Livak KJ, Starcich B, Josephs SF, Doran ER, Rafalski JA, Whitehorn EA, Baumeister K, Ivanoff L, Petteway SR Jr, Pearson ML, Lautenberger JA, Papas TS, Ghrayeb J, Chang NT, Gallo RC and Wong- Staal F (1985) Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313: 277–284
Segrest JP, De Loof H, Dohlman JG, Brouillette CG, Anantharamaiah GM (1990) Amphipathic helix motif: classes and properties. Proteins Struct Funct Genet 8: 103–117
Sharp PM, Robertson DL, Gao F, Hahn BH (1994) Origins and diversity of human immunodeficiency viruses. AIDS 8 [Suppl]: S27–S42
Shibata R, Miura T, Hayami M, Ogawa K, Sakai H, Kiyomasu T, Ishimoto A, Adachi A (1990) Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIVAGM. J Virol 64: 742–747
Tristem M, Marshall C, Karpas A, Petrik J, Hill F (1990) Origin of vpx in lentiviruses. Nature 347:341–342
Tristem M, Marshal C, Karpas A, Hill F (1992) Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J 11: 3405–3412
Venet A, Bourgault I, Aubertin A-M, Kieny M-P, Levy J-P (1992) Cytotoxic T lymphocyte response against multiple simian immunodeficiency virus (SIV) Proteins in SIV-infected macaques. J Immunol 148: 2899–2908
Viglianti GA, Sharma PL, Mullilns JI (1990) Simian immunodeficiency virus displays complex patterns of RNA splicing. J Virol 64: 4207–4216
Wain-Hobson S, Sonigo P, Danos O, Cole S, Alizon M (1985) Nucleotide sequence of the AIDS virus, LAV. Cell 40: 9–17
Westervelt P, Henkel, T, Trowbridge DB, Orenstein J, Heuser J, Gendelman HE, Ratner L (1992) Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants. J Virol 66: 3925–3931
Wu X, Boeke JD, Natsoulis G, Hahn BH, Kappes JC (1993) HIV/SIV virion associated accessory genes mediate efficient packaging of nuclease fusion proteins into the virus particle. Presented at the 1st National conference on human retroviruses and related infections, Washington DC
Wu X, Kappes JC (1993) Identification of a nuclear targeting signal within the human immunodeficiency virus type-2 Vpx protein. Presented at the 1993 Cold Spring Harbor Laboratory symposium on retroviruses
Wu X, Conway JA, Kim J, Kappes JC (1994) Localization of the Vpx packaging signal within the C-terminus of the HIV-2 Gag Precursor protein. J Virol 68: (in press)
Yu X-F, Ito S, Essex M, Lee T-H (1988) A naturally immunogenic virion-associated protein specific for HIV-2 and SIV. Nature 335: 262–265
Yu X-F, Yu Q-C, Essex M, Lee T-H (1991) The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophages. J Virol 65: 5088–5091
Yu X-F, Matsuda Z, Yu Q-C, Lee T-H, Essex M (1993) Vpx of Simian immunodeficiency virus is localized primarily outside the virus core in mature virions. J Virol 67: 4386–4390
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kappes, J.C. (1995). Viral Protein X. In: Chen, I.S.Y., Koprowski, H., Srinivasan, A., Vogt, P.K. (eds) Transacting Functions of Human Retroviruses. Current Topics in Microbiology and Immunology, vol 193. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78929-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-78929-8_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78931-1
Online ISBN: 978-3-642-78929-8
eBook Packages: Springer Book Archive